St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on December 23, 2025

Dec. 23, 2025

Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate

GlobeNewswire

Dec. 23, 2025

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

GlobeNewswire

Dec. 23, 2025

HealthLynked Announces Strategic Consulting Partnership With PBACO to Accelerate Payer Integration and Value-Based Care

GlobeNewswire

Dec. 23, 2025

Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

GlobeNewswire

Dec. 23, 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

GlobeNewswire

Dec. 23, 2025

Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation

GlobeNewswire

Dec. 23, 2025

Akari Therapeutics Initiates GMP Manufacturing of AKTX-101 ADC Program to Support Phase 1 First-in-Human Clinical Trial

GlobeNewswire

Dec. 23, 2025

EMJX Expands Risk-Intelligence Framework with Prediction-Market Probability Data to Enhance Treasury Stress Detection

GlobeNewswire

Dec. 23, 2025

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

GlobeNewswire

Dec. 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

GlobeNewswire

Dec. 23, 2025

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Dec. 23, 2025

MannKind Shares FUROSCIX® Business Updates

GlobeNewswire

Dec. 23, 2025

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

GlobeNewswire

Dec. 23, 2025

Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months

GlobeNewswire

Dec. 23, 2025

Iterum Therapeutics Provides Business Update

GlobeNewswire

Dec. 23, 2025

Immuneering to Announce 12-Month Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on January 7, 2026

GlobeNewswire

Dec. 23, 2025

Cassava Announces Agreement to Settle Securities Class Action Litigation

GlobeNewswire

Dec. 23, 2025

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

GlobeNewswire

Dec. 23, 2025

CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

GlobeNewswire

Dec. 23, 2025

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

GlobeNewswire